HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

lipoplatin

liposomal cisplatin formulation formed from cisplatin and liposomes composed of dipalmitoyl phosphatidyl glycerol (DPPG), soy phosphatidyl choline (SPC-3), cholesterol and methoxy-polyethylene glycol-distearoyl phosphatidylethanolamine (mPEG2000-DSPE); has no nephrotoxicity and lacks the serious side effects of cisplatin
Networked: 26 relevant articles (3 outcomes, 13 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Boulikas, Teni: 7 articles (09/2010 - 07/2004)
2. Fortin, David: 3 articles (06/2015 - 04/2010)
3. Paquette, Benoit: 3 articles (06/2015 - 04/2010)
4. Sanche, Léon: 3 articles (06/2015 - 04/2010)
5. Froudarakis, Marios E: 3 articles (04/2011 - 01/2007)
6. Mongiat, Maurizio: 2 articles (11/2014 - 12/2013)
7. Celegato, Marta: 2 articles (11/2014 - 12/2013)
8. Borghese, Cinzia: 2 articles (11/2014 - 12/2013)
9. Casagrande, Naike: 2 articles (11/2014 - 12/2013)
10. Colombatti, Alfonso: 2 articles (11/2014 - 12/2013)

Related Diseases

1. Neoplasms (Cancer)
2. Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
3. Adenocarcinoma
4. Glioma (Gliomas)
5. Vomiting

Related Drugs and Biologics

1. Cisplatin (Platino)
2. gemcitabine
3. Platinum
4. Proteins (Proteins, Gene)
5. 1L-6-hydroxymethyl-chiro-inositol 2(R)-2-O-methyl-3-O-octadecylcarbonate
6. Carboplatin (JM8)
7. Fluorouracil (Carac)
8. oxaliplatin (Eloxatin)
9. Biological Markers (Surrogate Marker)
10. Liposomes (Liposome)

Related Therapies and Procedures

1. Drug Therapy (Chemotherapy)
2. Radiotherapy
3. Heterologous Transplantation (Xenotransplantation)
4. Intravenous Injections
5. Intravenous Infusions